 hepat patient liver transplant object preval antibodi viru anti-hcv patient liver transplant relat anti-hcv post-transpl hepat design retrospect cohort patient serum sampl patient liver transplant sixty-six patient month follow-up pretranspl post-transpl serum sampl avail studi relat anti-hcv post-transpl hepat measur sera anti-hcv enzyme-link immunosorb assay elisa posit confirmatori test patient biopsi week specimen abnorm find main result onli patient chronic non-a non-b hepat alcohol cirrhosi chronic hepat infect anti-hcv posit patient form chronic liver diseas acut liver failur due non-a non-b hepat anti-hcv posit transplant loss anti-hcv frequent acquisit rare hepat graft patient incid similar anti-hcv neg anti-hcv-posit patient conclus hepat viru common caus chronic liver diseas patient liver transplant anti-hcv patient acut liver failur previou hcv infect detect anti-hcv independ risk factor post-transpl hepat